Literature DB >> 21302125

Characteristics of chronic fatigue syndrome in a Japanese community population : chronic fatigue syndrome in Japan.

Masahide Hamaguchi1, Yutaka Kawahito, Noriyuki Takeda, Takahiro Kato, Takao Kojima.   

Abstract

This study seeks to estimate the prevalence of chronic fatigue syndrome (CFS) and assess the characteristics of CFS in a community population in Japan using laboratory tests and questionnaires for lifestyle, fatigue states, and depression states. The design of this study is a cross-sectional observational study. The setting of this study is a medical health checkup program in a general hospital. This study was conducted with 1,430 Japanese (867 men and 563 women), 20 to 78 years of age. We classified participants who complained of fatigue according to the case definition of CFS proposed by the Centers for Disease Control and Prevention in the USA in 1994. Alcohol, caffeine, catechin and total polyphenol consumption, smoking status, sleep duration, and physical activity were evaluated using questionnaires. The prevalence of CFS was 1.0% (95% CI 0.5-1.6%) of a community population in Japan. Although various lifestyle factors of the participants with CFS were similar to those without chronic fatigue, average sleep duration was significantly shorter among the participants with CFS (5.5 ± 0.8 h) compared to those without chronic fatigue (6.3 ± 0.9 h, P < 0.001). Proportion at subjects having average sleep duration of less than 6 h was 64.3% among the participants with CFS in contrast to only 15.0% in those without chronic fatigue (P < 0.001). Among the eight case-defining symptoms, "Unrefreshing sleep" had high sensitivity and high specificity for screening CFS in Japanese population (92.9% and 87.8%, respectively). The average sleep duration was notably shorter in Japanese suffering from CFS. Further longitudinal study is needed to evaluate the possibility of extreme short sleep duration as a major cause of CFS in Japan.

Entities:  

Mesh:

Year:  2011        PMID: 21302125     DOI: 10.1007/s10067-011-1702-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  56 in total

1.  Muscle versus brain: chronic fatigue syndrome.

Authors:  A R Lloyd
Journal:  Med J Aust       Date:  1990-11-05       Impact factor: 7.738

2.  Vitamin B status in patients with chronic fatigue syndrome.

Authors:  L C Heap; T J Peters; S Wessely
Journal:  J R Soc Med       Date:  1999-04       Impact factor: 5.344

3.  Is physical deconditioning a perpetuating factor in chronic fatigue syndrome? A controlled study on maximal exercise performance and relations with fatigue, impairment and physical activity.

Authors:  E Bazelmans; G Bleijenberg; J W Van Der Meer; H Folgering
Journal:  Psychol Med       Date:  2001-01       Impact factor: 7.723

4.  [A study on a self-rating depression scale (author's transl)].

Authors:  K Fukuda; S Kobayashi
Journal:  Seishin Shinkeigaku Zasshi       Date:  1973-10

5.  Sleep duration, sleep quality and cardiovascular disease mortality among the elderly: a population-based cohort study.

Authors:  Etsuji Suzuki; Takashi Yorifuji; Kazumune Ueshima; Soshi Takao; Masumi Sugiyama; Toshiki Ohta; Kazuko Ishikawa-Takata; Hiroyuki Doi
Journal:  Prev Med       Date:  2009-06-30       Impact factor: 4.018

6.  Chronic fatigue syndrome in northern Nevada.

Authors:  S A Daugherty; B E Henry; D L Peterson; R L Swarts; S Bastien; R S Thomas
Journal:  Rev Infect Dis       Date:  1991 Jan-Feb

Review 7.  A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis.

Authors:  N C Briggs; P H Levine
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.

Authors:  K Kawai; A Kawai
Journal:  Intern Med       Date:  1992-03       Impact factor: 1.271

9.  Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy.

Authors:  R Wong; G Lopaschuk; G Zhu; D Walker; D Catellier; D Burton; K Teo; R Collins-Nakai; T Montague
Journal:  Chest       Date:  1992-12       Impact factor: 9.410

10.  Perception versus polysomnographic assessment of sleep in CFS and non-fatigued control subjects: results from a population-based study.

Authors:  Matthias Majer; James F Jones; Elizabeth R Unger; Laura Solomon Youngblood; Michael J Decker; Brian Gurbaxani; Christine Heim; William C Reeves
Journal:  BMC Neurol       Date:  2007-12-05       Impact factor: 2.474

View more
  13 in total

1.  Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Santiago Herrera; Wilfred C de Vega; David Ashbrook; Suzanne D Vernon; Patrick O McGowan
Journal:  Epigenetics       Date:  2018-12-05       Impact factor: 4.528

Review 2.  Fatigue in rheumatic diseases.

Authors:  Sevinç Can Sandıkçı; Zeynep Özbalkan
Journal:  Eur J Rheumatol       Date:  2015-09-01

Review 3.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

4.  Prevalence, incidence, and classification of chronic fatigue syndrome in Olmsted County, Minnesota, as estimated using the Rochester Epidemiology Project.

Authors:  Ann Vincent; Dana J Brimmer; Mary O Whipple; James F Jones; Roumiana Boneva; Brian D Lahr; Elizabeth Maloney; Jennifer L St Sauver; William C Reeves
Journal:  Mayo Clin Proc       Date:  2012-11-08       Impact factor: 7.616

5.  Translation of quality of life scale for pediatric patients with Fabry disease in Japan.

Authors:  Yuta Koto; Yoko Lee; Nozomi Hadano; Wakana Yamashita; Chikara Kokubu; Uma Ramaswami; Norio Sakai
Journal:  Mol Genet Metab Rep       Date:  2022-03-03

Review 6.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kjetil Gundro Brurberg; Marita Sporstøl Fønhus; Lillebeth Larun; Signe Flottorp; Kirsti Malterud
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

7.  The association between daytime napping and cognitive functioning in chronic fatigue syndrome.

Authors:  Zoe M Gotts; Jason G Ellis; Vincent Deary; Nicola Barclay; Julia L Newton
Journal:  PLoS One       Date:  2015-01-09       Impact factor: 3.240

8.  Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012.

Authors:  Inger Johanne Bakken; Kari Tveito; Nina Gunnes; Sara Ghaderi; Camilla Stoltenberg; Lill Trogstad; Siri Eldevik Håberg; Per Magnus
Journal:  BMC Med       Date:  2014-10-01       Impact factor: 8.775

9.  The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis.

Authors:  Samantha Johnston; Ekua W Brenu; Donald Staines; Sonya Marshall-Gradisnik
Journal:  Clin Epidemiol       Date:  2013-03-26       Impact factor: 4.790

10.  The Relationship Between Improvement in Insomnia Severity and Long-Term Outcomes in the Treatment of Chronic Fatigue.

Authors:  Daniel Vethe; Håvard Kallestad; Henrik B Jacobsen; Nils Inge Landrø; Petter C Borchgrevink; Tore C Stiles
Journal:  Front Psychol       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.